Tripeptides Restore the Number of Neuronal Spines under Conditions of In Vitro Modeled Alzheimer’s Disease


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

In primary culture of mouse hippocampal neurons, peptide EDR (200 ng/ml) under conditions of amyloid synaptotoxicity (a model of Alzheimer’s disease) increased the number of mushroom spines by 71% and returned this parameter to the normal level. Under the same conditions, tripeptide KED (200 ng/ml) increased the number of mushroom spines in hippocampal neurons by 20%. Tripeptide EDR can be recommended for further experimental study as a candidate neuroprotective agent for prevention and treatment of Alzheimer’s disease.

About the authors

N. A. Kraskovskaya

Peter the Great Saint Petersburg Polytechnic University

Email: miayy@yandex.ru
Russian Federation, St. Petersburg

E. O. Kukanova

St. Petersburg Institute of Bioregulation and Gerontology

Email: miayy@yandex.ru
Russian Federation, St. Petersburg

N. S. Lin’kova

Peter the Great Saint Petersburg Polytechnic University; St. Petersburg Institute of Bioregulation and Gerontology

Author for correspondence.
Email: miayy@yandex.ru
Russian Federation, St. Petersburg; St. Petersburg

E. A. Popugaeva

Peter the Great Saint Petersburg Polytechnic University

Email: miayy@yandex.ru
Russian Federation, St. Petersburg

V. Kh. Khavinson

St. Petersburg Institute of Bioregulation and Gerontology; I. P. Pavlov Institute of Physiology, Russian Academy of Sciences

Email: miayy@yandex.ru
Russian Federation, St. Petersburg; St. Petersburg


Copyright (c) 2017 Springer Science+Business Media, LLC

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies